tiprankstipranks
Trending News
More News >
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market

Context Therapeutics (CNTX) Financial Statements

Compare
227 Followers

Context Therapeutics Financial Overview

Context Therapeutics's market cap is currently $277.48M. The company's EPS TTM is $-0.14; its P/E ratio is -2.38; Context Therapeutics is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -39.70M$ -29.92M$ -25.07M$ -15.38M$ -10.53M
EBITDA$ -39.70M$ -29.91M$ -25.06M$ -14.87M$ -10.39M
Net Income$ -36.12M$ -26.73M$ -23.96M$ -14.84M$ -10.46M
Balance Sheet
Cash & Short-Term Investments$ 66.00M$ 94.43M$ 14.45M$ 35.50M$ 49.64M
Total Assets$ 68.49M$ 98.13M$ 16.06M$ 37.97M$ 51.31M
Total Debt$ 112.06K$ 219.38K$ 0.00$ 55.08K$ 0.00
Net Debt$ -65.88M$ -94.21M$ -14.45M$ -35.44M$ -49.64M
Total Liabilities$ 8.02M$ 2.86M$ 4.19M$ 3.21M$ 3.03M
Stockholders' Equity$ 60.47M$ 95.27M$ 11.87M$ 34.76M$ 48.27M
Cash Flow
Free Cash Flow$ -33.95K$ -29.31M$ -21.05M$ -14.09M$ -9.05M
Operating Cash Flow$ 0.00$ -14.56M$ -21.05M$ -13.55M$ -8.80M
Investing Cash Flow$ -2.03M$ -14.76M$ 0.00$ -536.84K$ -250.00K
Financing Cash Flow$ -15.27K$ 109.29M$ 0.00$ -102.07K$ 58.39M
Currency in USD

Context Therapeutics Earnings and Revenue History

Context Therapeutics Debt to Assets

Context Therapeutics Cash Flow

Context Therapeutics Forecast EPS vs Actual EPS